Caitlin Cronin
Stock Analyst at Canaccord Genuity
(4.22)
# 343
Out of 5,124 analysts
46
Total ratings
52.94%
Success rate
18.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENOV Enovis | Maintains: Buy | $58 → $50 | $26.64 | +87.69% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.69 | +2.11% | 6 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Buy | $90 → $105 | $87.31 | +20.26% | 2 | Dec 17, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $72 → $85 | $72.80 | +16.76% | 3 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $32.73 | +13.05% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $1.18 | +238.98% | 5 | Nov 18, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $36 → $34 | $32.81 | +3.63% | 4 | Nov 11, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $21.04 | +18.82% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $36.01 | +61.07% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $7.44 | +101.61% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $5.80 | -31.03% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $89.92 | +44.57% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $2.17 | +453.00% | 1 | Nov 14, 2023 |
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $26.64
Upside: +87.69%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.69
Upside: +2.11%
Globus Medical
Dec 17, 2025
Maintains: Buy
Price Target: $90 → $105
Current: $87.31
Upside: +20.26%
Establishment Labs Holdings
Dec 17, 2025
Maintains: Buy
Price Target: $72 → $85
Current: $72.80
Upside: +16.76%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $32.73
Upside: +13.05%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $1.18
Upside: +238.98%
Smith & Nephew
Nov 11, 2025
Maintains: Hold
Price Target: $36 → $34
Current: $32.81
Upside: +3.63%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $21.04
Upside: +18.82%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $36.01
Upside: +61.07%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $7.44
Upside: +101.61%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $5.80
Upside: -31.03%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $89.92
Upside: +44.57%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $2.17
Upside: +453.00%